0001209191-14-075572.txt : 20141215
0001209191-14-075572.hdr.sgml : 20141215
20141215212352
ACCESSION NUMBER: 0001209191-14-075572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141215
FILED AS OF DATE: 20141215
DATE AS OF CHANGE: 20141215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LARSON JOHN WILLIAM
CENTRAL INDEX KEY: 0001234387
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 141288220
MAIL ADDRESS:
STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100
STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-15
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001234387
LARSON JOHN WILLIAM
C/O SANGAMO BIOSCIENCES INC., POINT
RICHMOND TECH CNTR, 501 CANAL BLVD.
RICHMOND
CA
94804
1
0
0
0
Common Stock
2014-12-15
4
M
0
10000
6.41
A
224660
D
Common Stock
2014-12-15
4
M
0
5000
5.03
A
229660
D
Common Stock
2014-12-15
4
S
0
10000
16.2829
D
214660
D
Stock Option (Right to Buy)
6.41
2014-12-15
4
M
0
10000
0.00
D
2021-05-31
Common Stock
10000
0
D
Stock Option (Right to Buy)
5.03
2014-12-15
4
M
0
5000
0.00
D
2022-06-20
Common Stock
5000
5000
D
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $16.38, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
All shares underlying this option are vested and immediately exercisable.
/s/ Florence Tam, Attorney-in-Fact
2014-12-15